ExtraOrtho™ is an early-stage orthopedic company. The company's first product is an external fixation trauma device targeting the 300 million dollar US market. This unique device provides greater ease of use for the physician and more options for application. There are three products currently being developed and the company expects to expand this R&D pipeline in the next two years. Their first product has received FDA clearance for sale. ExtraOrtho's name was changed in May 2009 from QFx Technologies to ExtraOrtho.

Click here to visit their website.